Atlas Trials

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

Clinical trial NCT03947437 · UNKNOWN

Trial details

NCT number
NCT03947437
Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leprosy
Start date
2024-02-01
Primary completion
2024-03-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.